Premier Shockwave, Inc.
Developed in 1991 and widely used throughout Europe, the OssaTron® is the first shockwave device specifically designed and FDA approved for orthopaedic use.
A wealth of medical experience and state-of-the-art engineering have been built into the OssaTron®. Extensive clinical studies and tests have confirmed its safety and efficacy.
The OssaTron is approved by the FDA to treat chronic plantar fasciitis and chronic lateral epicondylitis that has failed to respond to conservative treatments.